MiMedx Group Inc
NASDAQ:MDXG
MiMedx Group Inc
Depreciation & Amortization
MiMedx Group Inc
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
MiMedx Group Inc
NASDAQ:MDXG
|
Depreciation & Amortization
-$1.9m
|
CAGR 3-Years
27%
|
CAGR 5-Years
23%
|
CAGR 10-Years
-6%
|
|
Abbvie Inc
NYSE:ABBV
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is MiMedx Group Inc's Depreciation & Amortization?
Depreciation & Amortization
-1.9m
USD
Based on the financial report for Dec 31, 2023, MiMedx Group Inc's Depreciation & Amortization amounts to -1.9m USD.
What is MiMedx Group Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
-6%
Over the last year, the Depreciation & Amortization growth was 16%. The average annual Depreciation & Amortization growth rates for MiMedx Group Inc have been 27% over the past three years , 23% over the past five years , and -6% over the past ten years .